ANVISA published Normative Resolution nº 392/2020 in an attempt to minimize the pandemic’s impact on the market. It defines exceptional criteria to render technical requirements more flexible for manufacturers and importers of medication and pharmaceutical products. This temporary measure is set to last while the emergency situation persists.
This content is available only in Portuguese. Find out more here.
